Ligand Pharmaceuticals Inc. (LGND)
Health Care ยท Pharmaceutical Preparations
Ligand Pharmaceuticals Inc. (LGND) is listed on Nasdaq, where its shares have traded since November 25, 1994. SentiSense covers Ligand Pharmaceuticals Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Todd C. Davis is its chief executive officer. The company reports 47 employees, and its corporate website is www.ligand.com.
About Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 402 institutions reported holding LGND, with 22.6 million shares worth $7.1 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Invesco Ltd. Of the 5 largest reported holders, all 5 added shares during the quarter.
More on LGND
- LGND sentiment: whether news and social coverage of Ligand Pharmaceuticals Inc. leans bullish or bearish, and the stories driving it.
- LGND ownership: all 402 reporting institutions, plus insider and congressional trades.
- LGND financials: revenue, net income, operating margin and free cash flow by quarter and year.
SentiSense also tracks daily options readings for Ligand Pharmaceuticals Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Ligand Pharmaceuticals Inc. do?
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine.
What sector is LGND in?
SentiSense classifies Ligand Pharmaceuticals Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does LGND stock trade?
Ligand Pharmaceuticals Inc. (LGND) is listed on Nasdaq, where its shares have traded since November 25, 1994.
Who is the CEO of Ligand Pharmaceuticals Inc.?
Todd C. Davis is the chief executive officer of Ligand Pharmaceuticals Inc..